AzTrials
AzTrials

Intensive Care Unit SyndromeDAARNCT02849756

Future of the Older Patients After Intensive Care Unit

An observational study of Intensive Care Unit Syndrome, run by Hôpital NOVO at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Estimate the future six months after the admission in an intensive care unit of the patients of 85 and more years old in terms of autonomy. Read more about this study

Who is it for?
Ages 85 years and older
Conditions the study is for
Intensive Care Unit Syndrome
What is being tested?
older in intensive care unit
How many people
240 participants
Where
1 siteFrance
Study dates
Feb 2015to Jun 2017
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 85 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Study population: Patients older than 85 years hospitalized in intensive care unit will be included in this study.

Who may be able to join

  • All patients over 85 years old staying in intensive car units

Who cannot join

  • Knaus D
  • No possibly of call (phone) 6 months after ICU admission
  • Patients who do not speak French
  • Patients do not accept the participation

Trial locations and contacts

1 site in 1 country.

France1 site
  • René-Dubos Hospital

    Pontoise, Val d'Oise, 95303

Other trials in France

About this study

Estimate the future six months after the admission in an intensive care unit of the patients of 85 and more years old in terms of autonomy.

Read the detailed description

The diverse studies published on the future of the elderly hospitalized in resuscitation place the limit very low, between 65 and 80 years. The feeling of a very bad forecast at these extreme ages pulls nevertheless a filter in the admission in ICU which has this day no scientific justification. The knowledge of the evolution after the hospitalization of these older patients can help to make certain decisions concerning as well the admission of these patients in ICU as the realization of invasive treatments.

After informal interrogation of numerous intensivists, it seems to take shape a bar around 85 years beyond which the forecast would be worse without more proof what consolidated the choice of this limit.

The reserved scores were already used in similar studies (simplified ALD).

Primary purpose :

  • Describe the survival and the evolution of the quality of life after a stay in resuscitation for very old patients.
  • The quality of life will be studied through a score of autonomy: the simplified ALD score.

The population will be described in general then by age bracket (more or less of 90 years old), according to the length of stay in ICU, the heavy treatments (artificial ventilation, renal replacement therapy) practiced, the initial gravity (score IGS 2). The impact of possible decisions of Limitation or Stop of Therapeutic Activates will also be taken into account.

Being tested
older in intensive care unit
Keywords
Intensive care, elderly, autonomy, Future, older patients, intensive care unit

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • older in intensive care unitOther

    It is an observational study with no intervention.

Study groups in NCT02849756
Study groupRoleWhat they receive
older in intensive care unitolder (age superior at 85 years) hospitalized in intensive care unit. A follow-up until 6 months after hospitalization will determine the evolution of the quality of life and others secondary outcomes.
Receives: Other: older in intensive care unit

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. ALD score

    Geriatric score of autonomy

    Measured: Six month

Secondary outcomes (1)
  1. survival

    survival

    Measured: Six month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jul 2016 (estimated)
  2. Study startFeb 2015
  3. Primary completionJun 2017
  4. Study completionJun 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
240 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02849756
Sponsor's protocol ID
CHRD0514
Acronym
DAAR
Status last verified
Jul 2019
First submitted
27 Jul 2016
Last updated
29 Jul 2019
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Khouli H, Astua A, Dombrowski W, Ahmad F, Homel P, Shapiro J, Singh J, Nallamothu R, Mahbub H, Eden E, Delfiner J. Changes in health-related quality of life and factors predicting long-term outcomes in older adults admitted to intensive care units. Crit Care Med. 2011 Apr;39(4):731-7. doi: 10.1097/CCM.0b013e318208edf8.

    PubMed 21263318
  • Lewis-Newby M, Curtis JR, Martin DP, Engelberg RA. Measuring family satisfaction with care and quality of dying in the intensive care unit: does patient age matter? J Palliat Med. 2011 Dec;14(12):1284-90. doi: 10.1089/jpm.2011.0138. Epub 2011 Nov 22.

    PubMed 22107108
  • Biston P, Aldecoa C, Devriendt J, Madl C, Chochrad D, Vincent JL, De Backer D. Outcome of elderly patients with circulatory failure. Intensive Care Med. 2014 Jan;40(1):50-6. doi: 10.1007/s00134-013-3121-7. Epub 2013 Oct 17.

    PubMed 24132383

Questions about this trial

What is this clinical trial studying?

An observational study of Intensive Care Unit Syndrome, run by Hôpital NOVO at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Jul 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

ALD score (time frame: Six month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02849756, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jul 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in